ISTA PHARMACEUTICALS INC - FORM 10-K - EX-23.2 - CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

Attached files

file	filename
EX-32.1 - CERTIFICATION OF CEO - SECTION 906 - ISTA PHARMACEUTICALS INC	dex321.htm
EX-32.2 - CERTIFICATION OF CFO - SECTION 906 - ISTA PHARMACEUTICALS INC	dex322.htm
EX-23.1 - CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM - ISTA PHARMACEUTICALS INC	dex231.htm
EX-31.1 - CERTIFICATION OF CEO - SECTION 302 - ISTA PHARMACEUTICALS INC	dex311.htm
EX-31.2 - CERTIFICATION OF CFO - SECTION 302 - ISTA PHARMACEUTICALS INC	dex312.htm
10-K - ISTA PHARMACEUTICALS FORM 10-K - ISTA PHARMACEUTICALS INC	d10k.htm

EXHIBIT 23.2

Consent of Independent Registered Public Accounting Firm

We consent to the incorporation by reference in the following Registration Statements of ISTA Pharmaceuticals, Inc.:

(1)

Registration Statement (Form S-3 No. 333-82726),

(2)

Registration Statement (Form S-3 No. 333-90994),

(3)

Registration Statement (Form S-3 No. 333-101120),

(4)

Registration Statement (Form S-3 No. 333-103820),

(5)

Registration Statement (Form S-3 No. 333-114815),

(6)

Registration Statement (Form S-3 No. 333-135799),

(7)

Registration Statement (Form S-3 No. 333-144344),

(8)

Registration Statement (Form S-3 No. 333-144345),

(9)

Registration Statement (Form S-3 No. 333-154713),

(10)

Registration Statement (Form S-3 No. 333-155187),

(11)

Registration Statements (Form S-8 Nos. 333-56042),

(12)

Registration Statements (Form S-8 No.333-103281),

(13)

Registration Statements (Form S-8 No 333-103276),

(14)

Registration Statements (Form S-8 No 333-103279),

(15)

Registration Statements (Form S-8 No 333-104434),

(16)

Registration Statements (Form S-8 No 333-119910),

(17)

Registration Statements (Form S-8 No 333-123026),

(18)

Registration Statements (Form S-8 No 333-129036),

(19)

Registration Statements (Form S-8 No 333-131793),

(20)

Registration Statements (Form S-8 No 333-138204),

(21)

Registration Statements (Form S-8 No 333-140577),

(22)

Registration Statements (Form S-8 No 333-149621),

(23)

Registration Statements (Form S-8 No 333-160348),

(24)

Registration Statements (Form S-8 No 333-164357),

(25)

Registration Statements (Form S-8 No 333-164358),

of our report dated February 17, 2009 (except Note 1, as to which the date is February 24, 2010), with respect to the consolidated financial statements and schedule of ISTA Pharmaceuticals, Inc. included in this Annual Report (Form 10-K) of ISTA Pharmaceuticals, Inc. for the year ended December 31, 2009.

/s/ Ernst & Young LLP

Orange County, California

February 24, 2010

Attached files

Stock widget

Investing forum

ISTA PHARMACEUTICALS INC Reports